NON-VASCULAR STENTS MARKET ANALYSIS

Non-vascular stents are a family of devices used for a variety of applications, including esophageal, biliary, colonic, tracheal, and bronchial implantations. Non-vascular stents employs minimally-invasive procedure for implantation. A minimally-invasive procedure offers faster recovery with reduced pain, and shorter hospital stay. Non-vascular stents are increasingly being used in various applications such as in the treatment of pulmonary, urological, and gastrointestinal diseases. The use of these stents is also increasing in the neural and ophthalmic fields.

The global non-vascular stents market was valued at US$ 934.7 million in 2017 and is expected to witness a robust CAGR of 4.7% over the forecast period (2017 - 2025).

Figure 1. Global Non-vascular Stents Market (US$ Mn), by Region, 2017

To learn more about this report, request a free sample copy

Source: Coherent Market Insights (2018)

To have a snippet of the report, request Report Sample

Increasing demand for minimally invasive procedures is expected to boost market growth

Increasing demand for minimally invasive procedures is expected to be a major factor driving the growth of the global non-vascular stents market. Non-vascular stents involve small accurate incisions, resulting in relatively smaller and lesser noticeable scars incurred by conventional surgical procedures that compromise on patient safety. Such a procedure is associated with faster recovery time, thus reducing a patient’s hospital stay. Furthermore, reduced hospital stay in turn, is expected to lower the risk of contracting hospital-acquired infections such as bloodstream infection, urinary tract infection, etc. among patients. These factors pose as major drivers boosting growth of the non-vascular stents market.

Increasing prevalence of chronic diseases is expected to drive market growth

Increasing prevalence of gastrointestinal, urological and pulmonary or airway diseases is expected to fuel the demand for non-vascular stents. Conditions such as chronic obstructive pulmonary disease (COPD), central airway obstruction, and asthma demand the use of pulmonary stents, to open up narrowed airways and ease the respiration process. According to WHO, more than three million people die each year from COPDs worldwide and 90% of these deaths in low and middle income countries. Furthermore, in U.S., every year, kidney disorders kills more people than prostate or breast cancer. For instance, in 2013, approximately 47,000 Americans died from kidney disease. Gastrointestinal diseases have been a major problem and cover a wide variety of parts of the system, (i.e. rectum, intestines, duodenum, and esophagus). Generally, these diseases are treated with palliation with the use of non-vascular stents. In recent years, non-vascular stents have been a standard treatment for removing occluding tumors in the gastrointestinal system.

Advancements in technology to accelerate the market growth

Increasing advancements in technology and material is aiding in the development of specially designed stents for used in various indications, is increasing the demand for non-vascular stents in a wide range of applications. For instance, the development of biodegradable polymers and bio-absorbable scaffolds is increasing the use of stents in pulmonary, gastrointestinal, urological, and biliary strictures. Poly capro-lactone, poly acryl amine, and poly lactic acid-glycolic acid are few of the newly designed biodegradable stent materials, which eliminate the need for stent removal. Nitinol is increasingly being utilized in non-vascular self-expandable stents, as it offers super elasticity and therefore is beneficial to the stent placement in difficult segments of an internal tract. However, high costs of non-vascular stents is expected to negatively impact growth of the market.

Major players operating in the global non-vascular stents market include Allium Medical, Boston Scientific, C.R. Bard, ELLA-CS, S.R.O, EndoChoice, Merit Endotek, Taewoong Medical, and Xlumena.